UNLOCKING LEGALITIES: Think Twice About Corrective Measures If You Have Devices With ‘Abnormal Potential For Damage’
This article was originally published in Clinica
Executive Summary
Do you manufacture or sell devices with an “abnormal potential for damage”? Chances are that many companies are just not sure. Here, Erik Vollebregt, partner at Axon Lawyers, explains to Amanda Maxwell what companies can learn from the preliminary ruling by the Court of Justice of the EU in the Boston Scientific/Guidant case involving cardiac implants, and about damage mitigation